Pharmacies May Tread On FDA Turf With HRTs
Warning letters recently sent by the Food and Drug Administration to pharmacies, alleging they made misleading claims about their bioidentical hormone replacement therapies, have set off a debate concerning where the...To view the full article, register now.
Already a subscriber? Click here to view full article